| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.2 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |